跳至主要内容
临床试验/NCT06213909
NCT06213909招募中不适用

A Retrospective Study of the Effects of Different Pathologic Phenotypes of Bullous Pemphigoid on Clinical Management and Prognosis

Xijing Hospital1 个研究点 分布在 1 个国家目标入组 318 人开始时间: 2024年1月11日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
318
试验地点
1
主要终点
Bullous Pemphigoid Disease Area Index (BPDAI) severity score

研究概览

简要总结

Bullous pemphigoid (BP) is a chronic autoimmune subepidermal blistering disease primarily affecting the elderly with a significant risk of mortality and morbidity. Various inflammatory cells such as eosinophils, lymphocytes, neutrophils and their granulopoiesis play an important role in the pathogenesis of BP. Infiltration of peripheral blood eosinophils, lymphocytes, and neutrophils into the skin is considered a major feature of BP, making it a heterogeneous disease with different histologic and clinical subtypes. This clinical study was conducted to further investigate the impact of different pathologic phenotypes of BP on the treatment and prognosis of the disease. A retrospective epidemiologic investigative approach was used,and case collection included demographic information, medical history, clinical manifestations, and histopathologic features. Including gender, age, duration of disease, number of days of hospitalization, mucosal involvement, clinical diagnosis before admission, histopathological diagnosis, laboratory tests, concomitant diseases, treatment and its changes in laboratory indexes before and after treatment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
0 Years 至 100 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • (1) Patients with Bullous Pemphigoid who were first hospitalized in the Department of Dermatology of Xijing Hospital
  • (2) Age 0-100 years old, gender is not limited.
  • (3) Diagnosis is confirmed by clinical, histopathologic, immunopathologic and/or anti-BP180 antibody tests.
  • (4) Complete skin histopathology information

排除标准

  • (1) Patients with Bullous Pemphigoid who were not first diagnosed in our hospital.
  • (2) Those who have received systemic glucocorticoid, immunosuppressant, biologic, or other drug therapy within the past month.

结局指标

主要结局

Bullous Pemphigoid Disease Area Index (BPDAI) severity score

时间窗: 10 years

We use BPDAI severity score as measure tool

次要结局

未报告次要终点

研究者

发起方
Xijing Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Retrospective Study of the Effects of Sub-pathologic... | 临床试验